Insider · CIK 0001177523
Walters Group
Files at ZNTL (Zentalis Pharmaceuticals, Inc.). First filing Jan 8, 2026, latest Aug 19, 2026.
In brief
Walters Group files SEC Form 4 as 10% owner at ZNTL (Zentalis Pharmaceuticals, Inc.). Since Jan 8, 2026, Walters Group has reported 2 open-market buys worth $23M and 0 open-market sells worth $0, the latest filed on Aug 19, 2026.
A track record needs three past buys with six months of prices behind them; Walters Group has 1, so none is measured yet.
The newest scored trade: bought $15M of ZNTL on Aug 14, 2026, filed Aug 19, 2026, scored 46 (moderate). In the last 12 months: 2 buys worth $23M and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ZNTL: Zentalis Pharmaceuticals, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 46Moderate | ZNTLbuy Zentalis Pharmaceuticals, Inc. | $15M 4,335,000 shares | +32% | +178% from low-46% from high | |
| 50Moderate | ZNTLbuy Zentalis Pharmaceuticals, Inc. | $7.8M 6,459,973 shares | +92% | +30% from low-58% from high |
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 14, 2026 | ZNTL Zentalis Pharmaceuticals, Inc. | POpen-market purchase Common Stock | +4,335,000 | $3.50 | $15M | 17,844,973 | Aug 19, 2026 |
| Dec 31, 2025 | ZNTL Zentalis Pharmaceuticals, Inc. | POpen-market purchase Common Stock | +6,459,973 | $1.20 | $7.8M | 13,509,973 | Jan 8, 2026 |
Questions about Walters Group
Answered from the filings on this page, as of the latest one.
Is Walters Group buying or selling?
In the last 12 months Walters Group reported 2 open-market buys worth $23M and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $15M of ZNTL on Aug 14, 2026. Grants, option exercises and tax withholding are not counted.
How did Walters Group's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Walters Group has 1.
Where does Walters Group file Form 4?
Walters Group has filed Form 4 at ZNTL (Zentalis Pharmaceuticals, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.